MUMBAI, India, July 24 -- Intellectual Property India has published a patent application (202418093824 A) filed by Calico Life Sciences LLC; and Abbvie Inc. on November 29, 2024, for Protein Tyrosine Phosphatase Inhibitors And Methods Of Use Thereof.
Inventors include Farney, Elliot; Shiroodi, Roohollah, Kazem; Xiong, Zhaoming; Zhang, Qingwei; O'Connor, Matthew; Halvorsen, Geoff; Zhao, Hongyu; Baumgartner, Christina Number; Frost, Jennifer, M.; Kym, Phil; Abbott, Jason, R. Filed On; Bogdan, Andrew; Economou, Christos; Wang, Xueqing; and Geoff.
The application for the patent was published on July 17, 2026, under issue no. 29/2026.
Abstract: Provided herein are compounds, compositions, and methods useful for inhibiting protein tyrosine phosphatase, e.g., protein tyrosine phosphatase non-receptor type 2 (PTPN2) and/or protein tyrosine phosphatase non-receptor type 1 (PTPN1), and for treating related diseases, disorders and conditions favorably responsive to PTPN1 or PTPN2 inhibitor treatment, e.g., a cancer or a metabolic disease.
Disclaimer: Curated by HT Syndication.
